Skip to main content
FRMM
NASDAQ Crypto Assets

Forum Markets Discloses Massive Executive Compensation Amidst Deep Losses and High Potential Dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$5.96
Mkt Cap
$78.732M
52W Low
$1.76
52W High
$174.6
52W Position info
239% above low
Off High info
97% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

FRMM has more than doubled off its 52-week low of $1.76 on light trading volume (0.3× avg).

Summary

Forum Markets' definitive proxy statement reveals exceptionally high executive and director compensation for 2025, primarily through equity awards, despite the company reporting a net loss exceeding its market capitalization. The filing also highlights significant potential share dilution and widespread insider trading reporting failures.


Key Events · Corporate Governance and Compliance · FRMM

  • Massive Executive & Director Compensation

    Several executives and directors received multi-million dollar compensation packages in 2025, largely in equity awards. CEO McAndrew Rudisill's total compensation was $20.27 million, and Director Jason New's was $18.39 million, primarily from warrants, in a year where the company reported a $450.5 million net loss.

  • High Potential Share Dilution

    The company has 6.62 million shares underlying outstanding options, warrants, and rights, plus 3.17 million shares available for future issuance under equity plans. This represents a potential dilution of approximately 72% of current outstanding shares.

  • Widespread Insider Trading Reporting Failures

    Multiple officers and directors, including the CEO and CFO, failed to timely file Section 16(a) reports (Forms 3 and 4) in 2025, indicating significant compliance issues.

  • Upcoming Shareholder Meeting

    The company will hold its annual meeting on August 19, 2026, to vote on the re-election of three Class II directors, an advisory resolution on executive compensation, and the ratification of auditors.


Analysis · FRMM · Crypto Assets

This definitive proxy statement reveals critical governance and financial concerns for Forum Markets. The disclosure of multi-million dollar executive and director compensation packages for 2025, predominantly in equity awards, is highly problematic given the company's reported net loss of $450.5 million for the same year, which significantly exceeds its current market capitalization. This level of compensation, even if largely non-cash and currently out-of-the-money, raises serious questions about executive incentives and shareholder alignment during a period of severe financial distress. Furthermore, the substantial potential dilution from outstanding equity awards and shares available under incentive plans, totaling approximately 72% of current outstanding shares, poses a significant overhang on the stock. The widespread failure of multiple key insiders to timely file required Section 16(a) reports underscores a concerning lack of internal controls and compliance, which aligns with the previously disclosed material weakness in internal controls. These issues, combined with ongoing related-party transactions, suggest a challenging environment for shareholder value and corporate governance. Investors should scrutinize the upcoming shareholder meeting proposals, particularly the advisory vote on executive compensation, in light of these disclosures.

At the time of this filing, FRMM was trading at $5.96 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $78.7M. The 52-week trading range was $1.76 to $174.60. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FRMM - Latest Insights

FRMM
Jul 08, 2026, 4:11 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $5.96
Real-time Price: $5.96 info
Change: $0 (0%) info
Market Cap: $78.732M info
FRMM
Jul 01, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.57
Real-time Price: $5.96 info
Change: +$0.390 (+7%) info
Market Cap: $78.732M info
FRMM
Jun 30, 2026, 6:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.44
Real-time Price: $5.96 info
Change: +$0.520 (+10%) info
Market Cap: $78.732M info
FRMM
May 15, 2026, 4:24 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.70
Real-time Price: $5.96 info
Change: +$2.26 (+61%) info
Market Cap: $78.732M info
FRMM
May 14, 2026, 8:13 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.47
Real-time Price: $5.96 info
Change: +$1.49 (+33%) info
Market Cap: $78.732M info
FRMM
May 14, 2026, 8:08 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $4.47
Real-time Price: $5.96 info
Change: +$1.49 (+33%) info
Market Cap: $78.732M info
FRMM
Apr 29, 2026, 8:13 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $5.23
Real-time Price: $5.96 info
Change: +$0.730 (+14%) info
Market Cap: $78.732M info
FRMM
Apr 29, 2026, 8:07 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $5.23
Real-time Price: $5.96 info
Change: +$0.730 (+14%) info
Market Cap: $78.732M info
FRMM
Apr 17, 2026, 8:38 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.46
Real-time Price: $5.96 info
Change: +$3.50 (+142%) info
Market Cap: $78.732M info
FRMM
Apr 08, 2026, 9:06 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.21
Real-time Price: $5.96 info
Change: +$3.75 (+170%) info
Market Cap: $78.732M info